
Richard Auchus, MD, PhD, FACE
Professor of Internal Medicine
Division of Metabolism, Endocrinology & Diabetes
University of Michigan
Ann Arbor, MI
Join Richard Auchus, MD, PhD, FACE, for a complimentary LIVE virtual webinar exploring classic congenital adrenal hyperplasia (CAH) outside of 21-hydroxylase deficiency (21-OHD) on Wednesday, September 23, 2026 at 4:00 PM EDT. This program will examine how the distinct genetic defects underlying non-21-OHD forms of classic CAH result in different biochemical profiles and clinical phenotypes that can influence disease severity, long-term outcomes, and management approaches.
Attendees will gain practical insights into the differential diagnosis of the various types of non‑21-OHD classic CAH, the laboratory and genetic testing used to distinguish them, and individualized monitoring and treatment strategies, including reproductive strategies in women with these disorders.
Click to Register for Free
Target Audience
The intended target audience for this program includes endocrinologists, primary care physicians, nurse practitioners, nurses, physician associates and endocrine care professionals who treat patients with rare endocrine diseases.
Disclaimer:
The statements and opinions expressed in the webinar are solely those of the authors and not of AACE. The information, opinions, and recommendations presented in the webinar are for general information only and any reliance on or use of the information provided is done at your own risk.
This activity is sponsored by Neurocrine Biosciences, Inc.
Richard J. Auchus, MD, PhD, FACE, is presenting on behalf of Neurocrine Biosciences as a paid consultant.
